Navigation Links
Using Early Stage Commercialization Activities to Build Long-Term Success for the Bottom Line
Date:12/18/2007

CHAPEL HILL, N.C., Dec. 18 /PRNewswire/ -- Despite all the scientific advancements in drug discovery and development, it's still a long and expensive trip from the lab to the marketplace. To make that investment of time and money pay off, best-in-class pharmaceutical companies have learned to inject commercial insights early in the product development process, according to research from Best Practices, LLC.

"It's clear early integration of commercialization activities pays off, be it eliminating an unpromising compound early in the development process or achieving success at product launch," said Chris Bogan, chief executive officer of Best Practices, LLC.

The 113-page study found that organizational form or structure is a critical enabler of early integration of commercial activities. Leading companies build an organizational structure that fosters commercialization excellence through integrated portfolio, project and process management programs across a compound's development cycles, according to the study.

The report, "From Genes to Giants: Best Practices in Early-Stage Commercialization," will help leaders in new product planning and market research learn best practices in early-stage product commercialization. The study contains a wealth of insights gleaned from interviews and benchmark surveys with pharma companies such as Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, and Pfizer.

To download a complimentary summary of the study, go to http://www3.best-in-class.com/rr892.htm .

Some of the findings to emerge from the study include:

-- Centralize early and late-stage commercialization functions to

cultivate better integration among people, resources, activities and

capital-intensive projects.

-- Employ integrated tools, techniques and tactics for portfolio

management and decision analysis to develop understanding and win

broad-based support for tough decisions.

-- Initiate lifecycle management analyses early in the new-product

development process to fully evaluate the potential for multiple

indications, line extensions and new formulations.

Firms that learn how to manage the people variables necessary to optimize product commercialization will win a competitive advantage in the marketplace, the study said.

Download additional findings in the complimentary report summary at: http://www3.best-in-class.com/rr892.htm or contact our Solution Specialists at (919) 403-0251 or bestpractices@best-in-class.com.

If you would like to speak to us about how our research can benefit your organization, please contact Cameron Tew, Manager of Research and Publishing at Best Practices, LLC at (919) 767-9246 or ctew@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years; our clients include 43 out of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Using coxibs and NSAIDs to treat osteoarthritis
2. Adverse housing conditions contribute to diabetes risk
3. Females avoid incest by causing male relatives to leave home
4. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
5. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
6. National Council of Negro Women (NCNW) Partners With Sherwin-Williams to Target Lead Risks in Neglected Housing
7. Using the Internet to Promote Exercise
8. Hazards of using crib bumper pads outweigh their benefits
9. Nosespray vaccine using aloe vera has exciting potential, researcher says
10. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
11. Genetic test announced for suicidal ideation in patients using antidepressant drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
(Date:10/2/2017)... -- AllianceRx Walgreens Prime, the combined central specialty pharmacy and ... manager Prime Therapeutics LLC (Prime), today officially began the ... of new signage at its headquarters in ... few other company-owned facilities across the country. This also ... whom will begin to see the AllianceRx Walgreens Prime ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
Breaking Medicine Technology: